Associate Director, US Virology Strategy and Policy - Government Affairs

Gilead Sciences, Inc.•Washington, DC

53d

About The Position

Gilead's mission is to discover, develop, and deliver therapies that will improve the lives of patients with life-threatening illnesses worldwide. The Associate Director of US Virology Strategy and Policy will support the development, implementation and management of projects in support of our virology portfolio within Government Affairs (GA). GA is responsible for managing the development of comprehensive US strategies that aim to shape public policy, both legislative and regulatory, using all relevant tools, including third-party advocacy and think tank engagement, public policy proposals and messaging development. The US Virology Strategy and Policy Associate Director will support the implementation of GA's strategies and be responsible for conducting policy analysis and research, building evidence-based messaging and argumentation, informing and developing policy and advocacy materials for internal and external audiences, and serve as a resource to U.S. government teams on policies that impact patient access to Gilead's innovative virology medicines, with an emphasis on the HIV portfolio. The ideal candidate possesses a deep knowledge of U.S. federal and state healthcare policy (Medicare and Medicaid) and the U.S. HIV/AIDS landscape; and an understanding of the pharmaceutical industry is preferred. This position will require strong leadership, partnership and teamwork. The Associate Director can be based in Foster City, CA or in our DC office.

Requirements

Ten years of experience with a Bachelor's degree in related field or eight years with a master's degree with relevant public or private sector experience in health care industry, or combination of experience and related advanced degree (MPH, MPP, MBA, PhD).
Deep understanding of U.S. government policies that impact the pharmaceutical industry; experience in HIV policy and/or infectious diseases policy preferred.
Demonstrated proficiency in policy-related strategy, analytics, communication, presentation and problem solving.
Experience delivering policy initiatives with demonstrated success.
Exceptional organizational and project management skills - demonstrated ability to independently manage multiple work streams.
Excellent verbal, analytical, written and interpersonal communications skills, particularly in interpreting complex technical rhetoric for general audience. English fluency required.
Demonstrated experience working collaboratively with internal and external partners.
Demonstrated experience managing strategy workshops and developing strategic documents, briefing documents and presentations. Strategy consulting training and/or experience preferred.
Domestic travel [25%] required

Nice To Haves

Strategy consulting training and/or experience preferred.
experience in HIV policy and/or infectious diseases policy preferred.

Responsibilities

Report to ED of Virology Strategy and Policy and will be a member of the virology strategy and policy team.
Support and help manage the annual strategic planning process, resulting in comprehensive government affairs strategies that shape the US public policy environment for existing and pipeline products in virology, primarily HIV.
Collaborate with members of across GA teams to define and evolve Gilead's U.S. virology policy positions in support of corporate mission to maintain patient-provider choice and access to innovative HIV treatment and prevention medicines
Support the execution of these strategies by GA organization and collaborate with cross-functional partners on key workstreams.
Anticipate trends in the external environment that will impact HIV markets and develop plans to address areas of concern.
Develop resources for internal and external stakeholders, including talking points, issue briefs, one-pagers, reports and presentations, that outline policy positions, implications, arguments and key messages.
Support engagement with influential third-party policy organizations, including health care policy experts, policy research organizations, and aligned patient advocacy groups.